Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples